COVID-19

The particles polygonal geometric art - Vaccine abstract vector illustration
Biotech

HHS unveils $500M universal vaccine development initiative

HHS is paying $500 million to develop a “universal” vaccine, or a single shot designed to protect against multiple strains of a pandemic-prone virus.
Gabrielle Masson May 1, 2025 2:55pm
decision path change of plans arrows business decision

Moderna's flu/COVID vaccine hit by deprioritization, FDA delay

May 1, 2025 7:24am
stop light green

HHS lifts stop work order on Vaxart's COVID-19 trial

Apr 28, 2025 12:48pm
drawing of a syringe and vial

Ex-FDA leader joins new initiative aiming to protect vaccine use

Apr 24, 2025 1:18pm
American flag red white and blue

Expect further market correction in tariff-driven era: PitchBook

Apr 18, 2025 7:51am
ocean covering up money lost investment

HHS delivers stop work order to Atlanta biotech, pulls funding

Apr 16, 2025 11:02am
More News

Vaxart lays off staffers after HHS demands halt to vaccine trial

Mar 21, 2025 8:36am

Curevo clinches $110M, nabs Moncef Slaoui to lead board

Mar 17, 2025 10:44am

Manufacturer Emergent invests in next-gen vax biotech

Mar 12, 2025 10:22am

Jury convicts 2 former biopharma leaders of fraud

Dec 11, 2024 10:26am